Literature DB >> 3099901

Treating ovarian cancer.

J W Sweetenham, G M Mead, J M Whitehouse, C J Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3099901      PMCID： PMC1342194          DOI： 10.1136/bmj.293.6559.1435-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

Authors:  J P Neijt; W W ten Bokkel Huinink; M E van der Burg; A T van Oosterom; R Vriesendorp; C D Kooyman; A C van Lindert; J V Hamerlynck; M van Lent; J C van Houwelingen
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321

2.  Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

Authors:  C J Williams; G M Mead; F R Macbeth; J Thompson; J M Whitehouse; H MacDonald; V J Harvey; M L Slevin; T A Lister; J H Shepherd
Journal:  J Clin Oncol       Date:  1985-11       Impact factor: 44.544

3.  Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.

Authors:  D G Decker; T R Fleming; G D Malkasian; M J Webb; J A Jeffries; J H Edmonson
Journal:  Obstet Gynecol       Date:  1982-10       Impact factor: 7.661

4.  Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycin.

Authors:  H W Bruckner; C J Cohen; J D Goldberg; B Kabakow; R C Wallach; G Deppe; E M Greenspan; S B Gusberg; J F Holland
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.